BAXALTA BIOSCIENCE INDIA PRIVATE LIMITED

Company Introduction

BAXALTA BIOSCIENCE INDIA PRIVATE LIMITED was incorporated on November 13, 2014, in India. It is a subsidiary, initially formed under Baxalta, which was later acquired by Shire, and subsequently, Shire was acquired by Takeda Pharmaceutical Company Limited. Therefore, it is part of the global Takeda enterprise. The company is primarily involved in the pharmaceutical sector, focusing on the research, development, manufacturing, marketing, and distribution of biopharmaceutical products. Its operations in India support the parent company's global strategy, aiming to provide innovative therapies for patients with complex and rare diseases, including those in hematology, immunology, and other therapeutic areas. The company manages the commercial activities, regulatory affairs, and market access for Takeda's biopharmaceutical portfolio within India.

Factory or Trader

BAXALTA BIOSCIENCE INDIA PRIVATE LIMITED functions primarily as a manufacturer. As part of a global biopharmaceutical group (Takeda), it is involved in the overall lifecycle of pharmaceutical products, which includes manufacturing processes, alongside significant operations in research, development, marketing, and distribution. While it certainly engages in the sale and distribution of its products (which could be seen as trading), its core identity and the nature of its parent company's business classify it as a biopharmaceutical manufacturer, even if the primary production facilities might be located globally and the Indian entity focuses on the final stages of manufacturing, packaging, and commercialization. It is not solely a trader.

BAXALTA BIOSCIENCE INDIA PRIVATE LIMITED manufactures or markets the following products:

* ADVATE [Antihemophilic Factor (Recombinant)]

* FEIBA [Anti-Inhibitor Coagulant Complex]

* IMMUNATE [Antihemophilic Factor (Human)]

* KOGENATE FS [Antihemophilic Factor (Recombinant)]

* RECOMBINATE [Antihemophilic Factor (Recombinant)]

* GAMMAGARD LIQUID [Immune Globulin Intravenous (Human)]

* HYQVIA [Immune Globulin Infusion, Human - with Recombinant Human Hyaluronidase]

* ALBUMIN [Human Albumin]

* FLEXBUMIN [Human Albumin]